← Back to Search

Alianza Latina Program for Dementia

Phase 1
Recruiting
Led By Jaime Perales Puchalt, PhD, MPH
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with mild cognitive impairment or dementia
Be older than 18 years old
Must not have
Not having a caregiver 18 years old or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the 15 months of the whole intervention period
Awards & highlights

Summary

This trial will test a new way to provide care for Latinos with dementia and their caregivers.

Who is the study for?
This trial is for Latinos aged 65+ living in the community with mild cognitive impairment or dementia, who have a caregiver and access to a cell phone with flat-fee texting. It's not for those without Latino identity, no diagnosis of cognitive issues, no caregiver, or lacking appropriate cell phone access.
What is being tested?
The study tests 'Alianza Latina,' where primary care practitioners are trained to better detect and manage dementia among Latinos. They refer patients to Health Navigators who offer care management and support services.
What are the potential side effects?
Since this trial focuses on training and support services rather than medication, traditional side effects aren't expected. However, participants may experience emotional or psychological impacts from discussing sensitive health information.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with mild cognitive impairment or dementia.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have a caregiver who is 18 or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the 15 months of the whole intervention period
This trial's timeline: 3 weeks for screening, Varies for treatment, and during the 15 months of the whole intervention period for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Importance of Navigators to providers
Overall participant satisfaction with the Navigator side of the intervention
Overall participant satisfaction with the clinic side of the intervention
+12 more
Secondary study objectives
Caregivers' burden
Caregivers' depression
Caregivers' quality of life
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Alianza LatinaExperimental Treatment1 Intervention
The main components of Alianza Latina are 1) providing primary care providers with education, training and tools for timely dementia diagnosis and optimal treatment and 2) providing Latino dementia patients with enhanced chronic care through bilingual Health Navigators.

Find a Location

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor
488 Previous Clinical Trials
172,355 Total Patients Enrolled
9 Trials studying Dementia
2,669 Patients Enrolled for Dementia
National Institute on Minority Health and Health Disparities (NIMHD)NIH
417 Previous Clinical Trials
1,370,749 Total Patients Enrolled
1 Trials studying Dementia
139 Patients Enrolled for Dementia
Jaime Perales Puchalt, PhD, MPHPrincipal InvestigatorKUMC

Media Library

Alianza Latina Clinical Trial Eligibility Overview. Trial Name: NCT04418232 — Phase 1
Dementia Research Study Groups: Alianza Latina
Dementia Clinical Trial 2023: Alianza Latina Highlights & Side Effects. Trial Name: NCT04418232 — Phase 1
Alianza Latina 2023 Treatment Timeline for Medical Study. Trial Name: NCT04418232 — Phase 1
~6 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top